Overview of systemic treatment in recurrent and advanced cervical cancer: a primer for radiologists
- Case Western Reserve University, Department of Radiology, UH Cleveland Medical Center (United States)
- Massachusetts General Hospital, Department of Radiology, Harvard Medical School (United States)
- Dana Farber Cancer Institute, Department of Imaging, Harvard Medical School (United States)
Imaging has a central role in surveillance of cervical cancer, guiding decision on when to initiate treatment for recurrent disease and to guide management in advanced cervical cancer. Due to the increased availability of pelvic radiation therapy, the rate of atypical presentation of recurrent disease has increased. Simultaneously, the array of systemic therapies now available for advanced cervical cancer has considerably expanded in the last few years, with therapies now available in mid and low-income countries. While pelvic recurrences are amenable of loco-regional treatment, recurrent disease may present with metastases to the thoracoabdominal organs, lymph nodes, bones, skin and brain, for which systemic treatment represent the standard of care. Besides combined chemotherapy regimens, alternative chemotherapies, biosimilars and immune checkpoint inhibitors are now available, each associated with a definite pattern of response and toxicity. In this review, after describing the typical and atypical presentations of recurrent and advanced cervical carcinoma on cross-sectional imaging, we will discuss systemic treatment for recurrent or advanced disease and their associated radiographic sequelae, in light of the newly available therapies.
- OSTI ID:
- 22923067
- Journal Information:
- Abdominal Radiology (Online), Journal Name: Abdominal Radiology (Online) Journal Issue: 4 Vol. 44; ISSN 2366-0058
- Country of Publication:
- United States
- Language:
- English
Similar Records
Genetics of rectal cancer and novel therapies: primer for radiologists
Para-aortic nodal metastases in early cervical carcinoma: long-term survival following extended-field radiotherapy